StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CRIS

Curis, Inc.

CRIS Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$5.15
+0.19 +3.83%

Key statistics

from XBRL data in SEC filings
Market cap
$201M
Revenue (TTM)
$7.06M
Net income (TTM)
-$21.2M
EPS (TTM)
$-0.58
P/E ratio
Dividend yield
Free cash flow
Cash
$15.0M
Total assets
$29.7M
Gross margin
52-week range
$3.60 – $39.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Delisting notice or listing-rule failure Jul 30, 2026 8-K Modified rights of security holders; Amended charter or bylaws Jul 2, 2026 8-K/A Amended charter or bylaws Jul 1, 2026 8-K Amended charter or bylaws Jul 1, 2026 8-K Shareholder vote results Jun 25, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results May 22, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Delisting notice or listing-rule failure May 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 24, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results Mar 17, 2026 8-K Delisting notice or listing-rule failure Feb 9, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Jan 8, 2026 8-K/A Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Terminated a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Other events Nov 6, 2025 8-K Delisting notice or listing-rule failure Oct 24, 2025 8-K Delisting notice or listing-rule failure Aug 22, 2025 8-K Other events Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jul 2, 2025 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results May 22, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Other events Mar 28, 2025 8-K Delisting notice or listing-rule failure Feb 27, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results; Other events May 23, 2024 8-K Regulation FD disclosure; Other events May 14, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 8, 2024